Health Products

Novamoxin (2017-11-07)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: Healthcare Professionals, General Public, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
35437011ANovamoxin
Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Granules For SuspensionDIN 00452149125 MG / 5 ML

Introduction

Affected products

Novamoxin

Reason

The homogeneity is out of specification in the affected lot.

Depth of distribution

Wholesalers and retailers (Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Quebec and Saskatchewan)
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime